Genetic susceptibility to nasopharyngeal carcinoma within the HLA-A locus in Taiwanese

被引:52
作者
Lu, CC
Chen, JC
Jin, YT
Yang, HB
Chan, SH
Tsai, ST
机构
[1] Natl Cheng Kung Univ, Coll Med, Dept Otolaryngol, Tainan 704, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Dept Pathol, Tainan 704, Taiwan
[3] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 704, Taiwan
[4] Ton Yen Gen Hosp, Dept Pathol, Hsinchu, Taiwan
[5] Natl Cheng Kung Univ, Coll Management, Dept Stat, Tainan 70101, Taiwan
关键词
nasapharyngeal carcinoma; HLA polymorphism; association study; microsatellite; Taiwan;
D O I
10.1002/ijc.10861
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
NPC is an epithelial tumor that is highly prevalent among the southern Chinese. Numerous studies have indicated that specific HLA haplotypes and genes within the HLA complex are associated with NPC. As a first effort to localize the gene responsible for susceptibility, the HLA-A, -8, and -A2 subtypes were examined for their association to NPC. Consistent with previous reports, frequencies of HLA-A2 [OR = 2.50, pc = 0.020 (study population); OR = 3.73, pc = 0.0030 (greater than or equal to40 years old)] were significantly higher in patients with NPC than in healthy controls. Two-locus analysis indicated that A2(+)B46(+) individuals are at greater risk for NPC than A2(-)B46(-) individuals in both the population studied and the greater than or equal to40-year-old group. This, however, may be due to the close linkage of these 2 genes. Moreover, A2(+)83(+) individuals were at higher risk than A2(-)B38(-) individuals in both the population studied and the greater than or equal to40-year-old group; A2 and B38 are not genetically linked. These findings suggest that B38 or B46 alone cannot confer a high risk of NPC but that, in conjunction with A2, 838 or B46 positivity greatly increases risk. None of 5 A2 subtypes identified from studied populations was significantly associated with NPC. Microsatellite marker D6S211, located 97 kb telomeric to HLA-A, was analyzed for its association with NPC. Allele 4 of D6S211 was significantly associated with NPC (OR = 3.97, pc = 0.0042). These results strongly support the hypothesis that genes associated with susceptibility to NPC in the HLA region are within the HLA-A locus. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:745 / 751
页数:7
相关论文
共 56 条
[1]  
AGATHANGGELOU A, 1995, AM J PATHOL, V147, P1152
[2]  
BAILAR JC, 1967, CANCER NASOPHARYNX, P18
[3]   Complete sequence and gene map of a human major histocompatibility complex [J].
Beck, S ;
Geraghty, D ;
Inoko, H ;
Rowen, L ;
Aguado, B ;
Bahram, S ;
Campbell, RD ;
Forbes, SA ;
Guillaudeux, T ;
Hood, L ;
Horton, R ;
Janer, M ;
Jasoni, C ;
Madan, A ;
Milne, S ;
Neville, M ;
Oka, A ;
Qin, S ;
Ribas-Despuig, G ;
Rogers, J ;
Shiina, T ;
Spies, T ;
Tamiya, G ;
Tashiro, H ;
Trowsdale, J ;
Vu, Q ;
Williams, L ;
Yamazaki, M .
NATURE, 1999, 401 (6756) :921-923
[4]   Nomenclature for factors of the HLA system, 1998 [J].
Bodmer, JG ;
Marsh, SGE ;
Albert, ED ;
Bodmer, WF ;
Bontrop, RE ;
Dupont, B ;
Erlich, HA ;
Hansen, JA ;
Mach, B ;
Mayr, WR ;
Parham, P ;
Petersdorf, EW ;
Sasazuki, T ;
Schreuder, GMT ;
Strominger, JL ;
Svejgaard, A ;
Terasaki, PI .
TISSUE ANTIGENS, 1999, 53 (04) :407-446
[5]  
BUELL P, 1974, CANCER RES, V34, P1189
[6]   A PROTECTIVE ASSOCIATION BETWEEN THE HLA-A2 ANTIGEN AND NASOPHARYNGEAL CARCINOMA IN US CAUCASIANS [J].
BURT, RD ;
VAUGHAN, TL ;
NISPEROS, B ;
SWANSON, M ;
BERWICK, M .
INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (04) :465-467
[7]  
Burt RD, 1996, CANCER EPIDEM BIOMAR, V5, P879
[8]   ELEVATED EXPRESSION OF ICAM1 (CD54) AND MINIMAL EXPRESSION OF LFA3 (CD58) IN EPSTEIN-BARR-VIRUS-POSITIVE NASOPHARYNGEAL CARCINOMA-CELLS [J].
BUSSON, P ;
ZHANG, Q ;
GUILLON, JM ;
GREGORY, CD ;
YOUNG, LS ;
CLAUSSE, B ;
LIPINSKI, M ;
RICKINSON, AB ;
TURSZ, T .
INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (06) :863-867
[9]  
Chan ASC, 2000, CANCER RES, V60, P5365
[10]   HLA AND NASOPHARYNGEAL CARCINOMA IN CHINESE - A FURTHER STUDY [J].
CHAN, SH ;
DAY, NE ;
KUNARATNAM, N ;
CHIA, KB ;
SIMONS, MJ .
INTERNATIONAL JOURNAL OF CANCER, 1983, 32 (02) :171-176